恒瑞医药:公司自主研发的1类创新药硫酸艾玛昔替尼片已在国内获批,用于成人重度斑秃患者

每日经济新闻
Feb 13

每经AI快讯,有投资者在投资者互动平台提问:想咨询恒瑞有没有可能研发真正的生发药剂呢?恒瑞医药(600276.SH)2月13日在投资者互动平台表示,公司坚持科技创新与国际化发展战略,促进公司业绩可持续增长,以更好的发展回馈股东。公司自主研发的1类创新药硫酸艾玛昔替尼片已在国内获批,用于成人重度斑秃患者。(记者 张明双)

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10